Table 2.
Variable | TLR2 genotype (%) | OR (95% CI) ins/ins vs ins/del | P‐value | OR (95% CI) ins/ins vs del carriers | P‐value | OR (95% CI) del/del vs others | P‐value | ||
---|---|---|---|---|---|---|---|---|---|
ins/ins | ins/del | del/del | |||||||
Healthy control subjects (n = 146) | 73 (50.0) | 65 (44.5) | 8 (5.5) | Reference | Reference | Reference | |||
NCGC (n = 289) | 126 (43.6) | 112 (38.8) | 51 (17.6) | 1.00 (0.66–1.52) | 1 | 1.29 (0.87–1.93) | 0.22 | 3.70 (1.70–8.02) † | 0.0009 † |
Age, sex‐adjusted OR = 6.06 (95% CI = 1.86–19.72), P = 0.003. Statistical significance was assessed using the two‐sided Fisher's exact test. CI, confidence interval; del carriers, ins/del + del/del; NCGC, non‐cardiac gastric cancer; OR, odds ratio.